Gauss

Akt1 (human) recombinant protein 100 µg

Réf. UGAP : 3755859 Réf. Fournisseur : 16078506 Réf. Constructeur : P5928
Akt1 (human) recombinant protein 100 µg
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.
Il ne reste que 0 exemplaires.

Points clés

Used for Func, SDS-PAGE

The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq]

En savoir plus

Garantie

Garantie 0 Mois

Description

Used for Func, SDS-PAGE

The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq]

Caractéristiques

Domaine de recherche
protéomique
Fournisseur
FISHER SCIENTIFIC S.A.S.
Marque
ABNOVA
Référence fabricant
P5928
Référence distributeur
16078506
Vendu par
100 ug
Quantité
N/A
Lieu de fabrication
Taiwan
Lieu de stockage
France
Délai de péremption à la date de livraison
12 mois
Code à barre
non
Soumis à carboglace
oui
Libellé produit fabricant
100ug akt1 (human) recombinant protein
Certification
RUO
Marquage CE DIV
non
Type de produit
protéine
Type de protéine
oui
Type d'antibiotique
non
Type d'enzyme
non
Température de conservation (°C)
-80 °C
Température de transport
carboglace
Dispositif stérile
non
Type d'acide nucléique extrait
non
Origine humaine
non
Sans composant animal
non
Matière dangereuse
non
Autres caractéristiques
Abnova Human AKT1 (NP_005154.1, 104 a.a. - 480 a.a.) Partial Recombinant Protein with His tag expressed in baculovirus infected Sf21 cells, Format: Liquid, Formulation: In 50mM Tris-HCl, 150mM NaCl, pH 7.5 (0.05% Brij35, 1mM DTT, 10% glycerol), Host
Classification REACH
non
Code douanier
38229000
Nomenclature Nacres
NA.55
Nomenclature CEA
SGP01
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA55
Nomenclature CNRS
NA55
Nomenclature CHU
18.551
Nomenclature DGOS
LD10AOOO
Type d'échantillon
protéine
Reprise en cas d’erreur client
non
Type d’application
ELISA, Western-Blot